MET and gastric cancer: Galectin-4 further contributes to peritoneal metastasis through interactions with specific membrane proteins such as mesenchymal–epithelial transition factor (c-MET) and CD44, both of which are known to be involved in gastric cancer progression and epithelial-to-mesenchymal transition [169].